XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Equity Investments (Tables)
9 Months Ended
Apr. 30, 2024
Cash and Cash Equivalents [Abstract]  
Schedule of Equity Investments

Equity investments consist of the following:

Schedule of Equity Investments

 

           
  

April 30, 2024

  

July 31, 2023

 
   (in thousands) 
Zedge, Inc. Class B common stock, 42,282 shares at April 30, 2024 and July 31, 2023  $102   $89 
Rafael Holdings, Inc. Class B common stock, 278,810 shares at April 30, 2024 and July 31, 2023   443    558 
Other marketable equity securities   169    1,497 
Fixed income mutual funds   4,130    4,054 
           
Current equity investments  $4,844   $6,198 
           
Visa Inc. Series C Convertible Participating Preferred Stock (“Visa Series C Preferred”)  $1,425   $1,263 
Convertible preferred stock—equity method investment   1,565    2,784 
Hedge funds   2,915    3,002 
Other   725    2,825 
           
Noncurrent equity investments  $6,630   $9,874 
Schedule of Carrying Value of Equity Investments

The changes in the carrying value of the Company’s equity investments without readily determinable fair values for which the Company elected the measurement alternative was as follows:

Schedule of Carrying Value of Equity Investments

 

                     
  

Three Months Ended

April 30,

  

Nine Months Ended

April 30,

 
  

2024

  

2023

  

2024

  

2023

 
   (in thousands) 
Balance, beginning of period  $1,719   $1,594   $1,632   $1,501 
Adjustment for observable transactions involving a similar investment from the same issuer   (25)    13    162    106 
Upward adjustment           130     
Redemption          (230)    
Impairments                
                    
Balance, end of the period  $1,694   $1,607   $1,694   $1,607 
Schedule of Unrealized Gains (losses) Gains for All Equity Investments

Unrealized losses for all equity investments measured at fair value included the following:

Schedule of Unrealized Gains (losses) Gains for All Equity Investments

 

                     
  

Three Months Ended
April 30,

  

Nine Months Ended
April 30,

 
  

2024

  

2023

  

2024

  

2023

 
   (in thousands) 
Net losses recognized during the period on equity investments  $(78)   $(480)  $(280)  $(2,649)
Less: net gains recognized during the period on equity investments sold during the period           130    18 
                     
Unrealized losses recognized during the period on equity investments still held at the reporting date  $(78)   $(480)  $(410)  $(2,667)

 

 

The unrealized losses for all equity investments measured at fair value in the table above included the following:

 

                 
  

Three Months Ended
April 30,

  

Nine Months Ended
April 30,

 
  

2024

  

2023

  

2024

  

2023

 
   (in thousands) 
Unrealized (losses) gains recognized during the period on equity investments:                
Rafael Class B common stock  $(61)   $11   $(115)  $20 
                     
Zedge Class B common stock  $(36)   $(9)  $13   $(33)

Summary of Changes in Equity Method Investments

The following table summarizes the change in the balance of the Company’s equity method investment:

Summary of Changes in Equity Method Investments

 

                     
  

Three Months Ended
April 30,

  

Nine Months Ended
April 30,

 
  

2024

  

2023

  

2024

  

2023

 
   (in thousands) 
Balance, beginning of period  $1,932   $(374)  $2,784   $1,001 
Purchase of convertible preferred stock   504    168    1,513    168 
Conversion of secured promissory notes into convertible preferred stock       4,038        4,038 
Equity in the net loss of investee   (529)   (532)   (1,704)   (1,544)
Amortization of equity method basis difference   (342)   (236)   (1,028)   (599)
                     
Balance, end of the period  $1,565   $3,064   $1,565   $3,064 

Summary of Statements of Operations

Summarized financial information of the EMI was as follows:

Summary of Statements of Operations

 

                     
  

Three Months Ended
April 30,

  

Nine Months Ended
April 30,

 
  

2024

  

2023

  

2024

  

2023

 
   (in thousands) 
Revenues  $3,351   $2,115   $11,156   $5,806 
Costs and expenses:                    
Direct cost of revenues   2,477    1,693    9,013    4,921 
Selling, general and administrative   2,366    2,080    6,892    5,488 
                     
Total costs and expenses   4,843    3,773    15,905    10,409 
                     
Loss from operations   (1,492)   (1,658)   (4,749)   (4,603)
Other income (expense), net   20    (266)   20    (1,108)
                     
Net loss  $(1,472)  $(1,924)  $(4,729)  $(5,711)